Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 723 results found. Search for [ Coronavirus vaccine update ]

Results 1 to 21 of 723
PB Jayakumar
November 28, 2020
Prime Minister Narendra Modi's visit to these facilities and discussions with the scientists are to help him get a first-hand perspective of the preparations, challenges and roadmap in India's vaccination plans


Manoj Sharma
November 27, 2020
New vaccines are rarely certified for efficacy above 90 per cent. Their efficacy improves as millions are vaccinated over decades. In fact, most vaccines get certified in the 40-60 per cent efficacy band


BusinessToday.In
November 27, 2020
India Stock Market Highlights Today: ICICI Bank, Airtel, Infosys, M&M were among the top losers today. On the other hand, Kotak Bank, NTPC, Maruti were among the top gainers


BusinessToday.In
November 26, 2020
India Stock Market Highlights Today: Bajaj Auto, M&M, L&T, HDFC, Bharti Airtel, Sun Pharma, UltraTech Cement, Titan and Tata Steel were among the top gainers on Sensex pack. On the other hand, IndusInd Bank, Infosys, Maruti and ONGC were among the laggards


BusinessToday.In
November 25, 2020
The speed is going to be that of a very severe cyclonic storm, which is 130-145kmph with gusting winds. Earlier, it was anticipated that the cyclone would peak on Wednesday, with gusting winds at 110 kmph.


BusinessToday.In
November 25, 2020
India Stock Market Highlights Today: Global equities were mostly buoyed today encouraged by news on the development of coronavirus vaccines and more assurance for a transition of power in the US to President-elect Joe Biden


BusinessToday.In
November 24, 2020
The cyclonic storm Nivar is expected to intensify further, clocking wind speeds in the range of 100-110 kmph, gusting to 120 kmph.


BusinessToday.In
November 24, 2020
India Stock Market Highlights Today: During the session, Sensex hit a lifetime high of 44,601 and Nifty touched record high of 13,079


BusinessToday.In
November 23, 2020
SpiceHealth has signed a Memorandum of Understanding with the Indian Council of Medical Research for setting up testing facilities and collection centres across the nation.


BusinessToday.In
November 23, 2020
Maharashtra cabinet minister on Monday also said that the state government is contemplating on this matter and might take the final call in the next eight days


BusinessToday.In
November 23, 2020
The panel-led by Dravida Munnetra Kazhagam (DMK) lawmaker Kanimozhi Karunanidhi will hear officials of pharmaceutical departments on the status of the COVID-19 vaccine


BusinessToday.In
November 23, 2020
Coronavirus vaccine update: Adar Poonawalla, the CEO of Serum Institute had recently said that his company might sell a two-shot COVID-19 vaccine for around Rs 500-600 for the general public


BusinessToday.In
November 23, 2020
India Stock Market Highlights Today: IndusInd Bank, followed by Bajaj Finserv, Bajaj Finance, Reliance Industries, ONGC, NTPC and Tata Steelwere among the top gainerz in the Sensex pack. On the other hand, HDFC, Asian Paints, ITC and Bharti Airtel were among the laggards


BusinessToday.In
November 22, 2020
USFDA Commissioner Stephen Hahn said that USFDA has been preparing for review of EUAs for COVID-19 vaccines for the past several months and requests will be processed \"as expeditiously as possible\"


BusinessToday.In
November 22, 2020
RIL, TCS, and Infosys suffered an erosion in their m-cap for the week ended Friday. However, HDFC Bank, HDFC Ltd, Bajaj Finance Ltd and Bharti Airtel finished with gains


BusinessToday.In
November 22, 2020
Bharat Biotech has started the phase- 3 trial of its potential COVID-19 vaccine, involving 26,000 volunteers this month across 25 centres in the country, including Hyderabad, Goa, Nagpur, Bhubaneswar, and Aligarh


BusinessToday.In
November 21, 2020
The participant was admitted to a hospital with viral pneumonitis, few days after being given the vaccine. He was discharged after a week.


Joe C Mathew
November 21, 2020
\"We expect emergency authorisation for Oxford-Astrazeneca vaccine to be sought in the UK. If so, it will give an opportunity for India regulator also (to consider such an option),\" says Dr Vinod Paul, chairman of the National Expert Group on Vaccine Administration for COVID-19


BusinessToday.In
November 21, 2020
Bharat Biotech, the developer of India's indigenous vaccine Covaxin, has said that it is planning to enrol about 2,000 participants each in metros for Phase-3 trials of its COVID-19 vaccine that began earlier this week


BusinessToday.In
November 21, 2020
Pfizer's CEO Albert Bourla confirmed the company's application and said in a video statement,  'It is with great pride and joy - and even a little relief - that I can say that our request for emergency use authorization for our COVID-19 vaccine is now in the FDA's hands.'


PAGES 1 OF 37  12345